Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location:Home > Pharma China Web Edition > Editorials    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Editorials
 
Revisiting the Basis of Your China Strategy in the Post-Covid New... 7/1/2020
Despite Stormy Days Ahead, Pockets of Hope and Opportunity Remain... 6/1/2020
Strategic Considerations for Pharma MNCs in the Post-Coronavirus ... 5/1/2020
Be Ready for the Dire Aftermath of the Post-Outbreak China Market... 4/1/2020
What Are the Lessons To Be Drawn from China's New Normal and the ... 2/28/2020
Annual Overview of the Chinese Pharmaceutical Sector 2019 and Out... 2/3/2020
U.S.-China Phase I Trade Deal - An Opportunity Window MNCs Must N... 1/2/2020
New Round of Negotiation for NRDL Access Begins as Big Pharma Bos... 12/3/2019
Finding the Right Formula for China Business Amid Cloudy Outlook 11/4/2019
Pharma Industry Face Unprecedented Price Pressure in Expanded 4+7... 9/30/2019
MNCs Must Rethink Their China Strategies as the Government Reveal... 9/2/2019
Hospital Market and MNCs Rose Higher in Q1/2019 amid Growing Unce... 8/8/2019
What Is the New 'New Normal' of Chinese Pharma Going To Be? 7/12/2019
Page:1/1  Total number of articles:13  [1]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links